These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 34063170)
1. New Insights into the Pathogenesis of Systemic Mastocytosis. Li Z Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063170 [TBL] [Abstract][Full Text] [Related]
2. FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis. Kasamon YL; Ko CW; Subramaniam S; Ma L; Yang Y; Nie L; Shord S; Przepiorka D; Farrell AT; McKee AE; Pazdur R Oncologist; 2018 Dec; 23(12):1511-1519. PubMed ID: 30115735 [TBL] [Abstract][Full Text] [Related]
3. A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase. Bibi S; Zhang Y; Hugonin C; Mangean MD; He L; Wedeh G; Launay JM; Van Rijn S; Würdinger T; Louache F; Arock M Oncotarget; 2016 Dec; 7(50):82985-83000. PubMed ID: 27783996 [TBL] [Abstract][Full Text] [Related]
4. Response Criteria in Advanced Systemic Mastocytosis: Evolution in the Era of KIT Inhibitors. Shomali W; Gotlib J Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804174 [TBL] [Abstract][Full Text] [Related]
5. Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurin. Gotlib J; Kluin-Nelemans HC; Akin C; Hartmann K; Valent P; Reiter A Expert Opin Biol Ther; 2021 Apr; 21(4):487-498. PubMed ID: 33063554 [TBL] [Abstract][Full Text] [Related]
6. European Medicines Agency review of midostaurin (Rydapt) for the treatment of adult patients with acute myeloid leukaemia and systemic mastocytosis. Tzogani K; Yu Y; Meulendijks D; Herberts C; Hennik P; Verheijen R; Wangen T; Dahlseng Håkonsen G; Kaasboll T; Dalhus M; Bolstad B; Salmonson T; Gisselbrecht C; Pignatti F ESMO Open; 2019 Nov; 4(6):. PubMed ID: 32392175 [TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor SAHA mediates mast cell death and epigenetic silencing of constitutively active D816V KIT in systemic mastocytosis. Lyberg K; Ali HA; Grootens J; Kjellander M; Tirfing M; Arock M; Hägglund H; Nilsson G; Ungerstedt J Oncotarget; 2017 Feb; 8(6):9647-9659. PubMed ID: 28038453 [TBL] [Abstract][Full Text] [Related]